Intra-Cellular Therapies, Inc. Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Intra-Cellular Therapies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Intra-Cellular Therapies, Inc. for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 2021 | ITCI | Intra-Cellular The ... | Durgam Suresh K. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 23,719 | 0 | 23,719 | |
| Feb 25 2021 | ITCI | Intra-Cellular The ... | Durgam Suresh K. | Chief Medical Offic ... | Option Exercise | A | 36.89 | 18,714 | 690,359 | 18,714 | |
| Feb 25 2021 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | A | 0.00 | 22,364 | 0 | 22,364 | |
| Feb 25 2021 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | A | 36.89 | 17,644 | 650,887 | 17,644 | |
| Feb 25 2021 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | A | 0.00 | 23,719 | 0 | 23,719 | |
| Feb 25 2021 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | A | 36.89 | 18,714 | 690,359 | 18,714 | |
| Feb 25 2021 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 0.00 | 67,769 | 0 | 67,769 | |
| Feb 25 2021 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 36.89 | 53,471 | 1,972,545 | 53,471 | |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Durgam Suresh K. | Chief Medical Offic ... | Option Exercise | M | 0.00 | 8,354 | 0 | 16,708 | |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Durgam Suresh K. | Chief Medical Offic ... | Sell | S | 38.87 | 200 | 7,774 | 23,104 | 23.3 K to 23.1 K (-0.86 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Durgam Suresh K. | Chief Medical Offic ... | Sell | S | 39.28 | 2,534 | 99,536 | 23,304 | 25.8 K to 23.3 K (-9.81 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Durgam Suresh K. | Chief Medical Offic ... | Buy | M | 0.00 | 8,354 | 0 | 25,838 | 17.5 K to 25.8 K (+47.78 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 11,139 | 0 | 22,278 | |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Sell | S | 38.90 | 600 | 23,340 | 45,339 | 45.9 K to 45.3 K (-1.31 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Sell | S | 39.26 | 4,584 | 179,968 | 45,939 | 50.5 K to 45.9 K (-9.07 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Buy | M | 0.00 | 11,139 | 0 | 50,523 | 39.4 K to 50.5 K (+28.28 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 10,442 | 0 | 20,886 | |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 38.91 | 1,200 | 46,692 | 0 | 1.2 K to 0 (-100.00 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 39.27 | 9,242 | 362,933 | 1,200 | 10.4 K to 1.2 K (-88.51 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 10,442 | 0 | 10,442 | 0 to 10.4 K |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 11,139 | 0 | 22,278 | |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 38.91 | 1,100 | 42,801 | 0 | 1.1 K to 0 (-100.00 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 39.28 | 10,039 | 394,332 | 1,100 | 11.1 K to 1.1 K (-90.12 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 11,139 | 0 | 11,139 | 0 to 11.1 K |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 27,847 | 0 | 55,695 | |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 38.91 | 3,100 | 120,621 | 1,133,392 | 1.1 M to 1.1 M (-0.27 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 39.27 | 24,747 | 971,815 | 1,136,492 | 1.2 M to 1.1 M (-2.13 %) |
| Feb 22 2021 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 27,847 | 0 | 1,161,239 | 1.1 M to 1.2 M (+2.46 %) |